Konferenzen  >  Medizin & Gesundheitswesen  >  Pharmakologie und Arzneimittelentwicklung

ILAE-Europe

The Course is held under the auspices of the ILAE Europe. The program is designed for junior researchers and clinicians (45 years and younger) working in the field of epilepsy treatment and related basic research. It is open to young neurologists, neuropediatricians, pharmacists, pharmacologists, neuropsychologists and neuroscientists. We are happy to inform you that a number of bursaries have been made available towards partially defraying the cost of accommodation expenses of bursary recipients, who will also have their registration fees waived.

Target Conferences Ltd.;     Tel.: [+972 3 517 5150];     Email: eilatedu@target-conferences.com

Eilat, epilepsy, course, education, treatment, drugs, pharma, pharmacological, international, research

CHI

Event Description: Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

We aim to meet your research needs. Visit numerous concurrent sessions for informative presentations, lively dialogue, and meaningful connections with peers. Customize your experience further through focused short courses, interactive group discussions, and networking options that help you engage with experts and solutions providers.

Our 22th Anniversary event brings back popular topics like immunomodulation, protein degraders, and RNA, plus new programs like emerging covalent strategies and synthetic biology.

Tel.: [781.972.5400];     Email: chi@healthtech.com

Uventia Global

In order to avoid contamination of the product, robust cleaning procedures must be performed. Our online meeting facilitates peers’ reflection and discussion on approaches to establishing and revising CV programs to meet regulatory requirements, verifying CV protocols and preventing ineffective or incorrect approaches to cleaning validation programs, risk based cleaning validation, selecting the right equipment/cleaning procedure combinations, testing for API residues and calculating residue limits, considerations on combining cleaning and sanitization, finding and developing practical analytical methods and sampling procedures.

Email: info@uventia.com

QRM, Cleaning Validation, Containment, Bioprocessing, Bioproduction, Aseptic, GMP, Regulatory Affairs, Quality Assurance, QA, Risk Management

Biochemie und Medizinische Chemie, Toxikologie,    Biotechnologie

Pharma Partnering Summit

The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.

Tel.: [441753253192];     Email: taiba@pharma-partneirng-summit.co.uk

Business Development, Licensing, Alliances, Collaboration, Partnership, External Innovation, Search and evaluation, M&A, Biotechnology, Pharmabiotech Year, Pharmaceutical

Oxford Global

"Join global innovators at our symposium focused on advanced drug target screening. Explore fragment, CRISPR, phenotypic, target-based, virtual, and structure-based screening methods. Engage with leaders to discuss best practices and advancements. Discover cutting-edge techniques in fragment and CRISPR screening for identifying novel drug targets, ensuring you stay at the forefront of drug discovery. Participate in discussions on enhanced cell screening platforms and virtual & structure-based approaches. The event concludes with the ‘Harnessing Advanced Screening Approaches for Drug Target Identification & Validation’ report, summarising key insights and methodologies for effective drug discovery utilisation."

Digital Marketing Executive;     Email: c.donohoe@oxfordglobal.com

Drug delivery, target identification, computational biology, medicinal chemistry

Biotechnologie,    Genomforschung und Bioinformatik

Oxford Global Conferences

Discover the latest advancements in biomarkers at the 8th Annual Biomarker & Precision Medicine US Congress. Join experts from global pharma, top biotechs, and renowned academic institutions to delve into emerging tools and strategies in translational science, diagnostics, and biomarker development.

Marketing Executive;     Email: l.staplehurst@oxfordglobal.com

Novel Biomarker Discovery, Identification & Characterization, Effective Clinical Biomarker Strategies, Multi-Omics For Precision Medicine, Emerging Strategies For Biomarker Validation & Data Analysis, High-Quality Biospecimens in Clinical Development & Precision Medicine, Innovative Tools & Technologies For Next-Gen Diagnostics

Pharma Partnering Summit

We are thrilled to bring the MedTech Partnering Summit to Brussels, a vibrant hub of MedTech innovation. This event is set to be the summit of MedTech partnering and deal-making, offering enhanced opportunities to connect, collaborate, and succeed. The MedTech Partnering Summit is an international event designed to provide exclusive opportunities for business development, Licensing, R&D collaborations, investment, fundraising, alliances, M&A, and all deal-making activities in the MedTech industry. This summit serves as a unique platform to connect with decision-makers, industry leaders, and key stakeholders from across the MedTech ecosystem.

Tel.: [441753253192];     Email: taiba@pharma-partneirng-summit.co.uk

Med Tech, Medical Technology, Healthcare Innovation, Biotechnology, Med Tech Partnership, Medical Devices, Health Tech, Digital Health, Med tech Networking, Medical Innovation, Biotech, Healthcare Partnerships, Medical research

Noveltics Group LLC

Welcome to the forefront of pharmaceutical innovation! Noveltics Group is thrilled to invite you to the International Pharma Congress which is going to be held during November 18-19, 2024 at Dubai, UAE , where groundbreaking discoveries, transformative technologies, and visionary leaders converge to shape the future of healthcare.

Tel.: [ +1-765-545-2593];     Email: advancedpharma@researcherstalk.com

Pharmacology, Drug Discover, Drug Development, Pharmaceutical Chemistry, Pharmacognosy, Natural Products, Medicinal Plants

MDPI

The IECV 2024 invites researchers from academia, as well as vaccine practitioners, to contribute original findings, novel ideas, scientific concepts, and new technologies and experiences to deal with immunology mechanisms, animal models for immunologic diseases, viral immunology, immunopathogenesis, vaccine development and efficacy evaluation, immune responses to vaccines, vaccine technology, vaccine vectors, adjuvants, and immunomodulators.

Email: iecv2024@mdpi.com

Immunology Mechanisms, Animal Models for Immunologic Diseases, Viral Immunology, Immunopathogenesis, Vaccine Development and Efficacy Evaluation, Immune Responses to Vaccines, Vaccine Technology, Vaccine Vectors Adjuvants and Immunomodulators

CHI

Drug Discovery Chemistry is a dynamic conference and networking event for drug discovery scientists working in pharma, biotech, and academia. One of the few events that reflects the new cross-functional and collaborative nature of drug discovery, our speakers and attendees are comprised primarily of pharma and biotech scientists, as well as key academic thought leaders working in translational research. Discussions of chemical tools and approaches to meet the practical (not theoretical) challenges of drug discovery are front and center. Speakers from industry include: Amgen, Astex Pharmaceuticals, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Chugai Pharmaceutical, Genentech, GSK, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, UCB Pharma, and more.

Tel.: [781.972.5400];     Email: chi@healthtech.com

The European Association for Cancer Research and Boehringer Ingelheim

We return to this topic for its second edition to focus on the basic and clinical aspects of the regulation of the Mitogen Activated Protein Kinase (MAPK) pathway, one of the most commonly mutated signalling pathways in human cancers. The programme will include new insights about the mechanisms of action of the new generation of pan-RAS inhibitors and rational combination therapies.

Email: christopher.iliffe@eacr.org

cancer research, oncology, MAPK pathway, small molecule inhibitors, intrinsic resistance, adaptive resistance, effective cancer therapy agents, pan-RAS inhibitors, gene regulation, target validation, drug development, clinical and translational opportunities, rational combination therapies, cross-resistance to immune modulators

Onkologie,    Molekularbiologie

The European Association for Cancer Research

This meeting will explore the burgeoning field of cancer persister cells, a rare subset of cells which have emerged over the last decade as a significant factor in cancer treatment failure. Unlike resistance cells, which harbour genetic alterations enabling survival despite therapy, persister cells exhibit transient drug tolerance through reversible, non-mutational mechanisms. Our conference on this topic will bring together investigators from across the world to delve into molecular mechanisms, therapeutic targets, and emerging clinical implications of cancer persister cells, fostering collaboration and community-building in this pivotal and rapidly growing area of research.

Email: christopher.iliffe@eacr.org

cancer research, oncology, cancer persister cells, cancer resistant cells, non-genetic drug resistance, treatment response, treatment success, treatment failure, molecular mechanisms of resistance and persistence, novel study methodologies, targeting vulnerabilities within persister cells, clinical implications and applications

Onkologie,    Molekularbiologie

pagesconferences

International Conference on Pharmacovigilance and Regulatory Affairs (ICPRA-2025), a premier event focusing on the latest developments in the field of Pharmacovigilance and Regulatory Affairs which is going to be held in Rome, Italy during March 24-26, 2025.

This Conference will bring together pharmacovigilance professionals, researchers, and experts from around the world to discuss the latest advancements in Pharmacovigilance and Regulatory Affairs. Join us for a day of education, networking, and knowledge exchange. This event will provide a valuable opportunity for the attendees to learn from each other’s work, exchange ideas, create networks and build collaborations.

Tel.: [910033064];     Email: icpra2025@pagesconferences.org

Pharmacovigilance Drug safety Drug Surveillance Pharmacology